Moreno-Delgado, D., Puigdellívol, M., Moreno, M., Rodríguez-Ruiz, M., Botta, J., Gasperini, P., . . . McCormick, P. J. (2020). Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington’s disease.
Chicago Style CitationMoreno-Delgado, David, et al. Modulation of Dopamine D1 Receptors Via Histamine H3 Receptors Is a Novel Therapeutic Target for Huntington’s Disease. 2020.
MLA CitationMoreno-Delgado, David, et al. Modulation of Dopamine D1 Receptors Via Histamine H3 Receptors Is a Novel Therapeutic Target for Huntington’s Disease. 2020.
Warning: These citations may not always be 100% accurate.